You have 6 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

myeloid

Showing 26 - 50 of 5,741
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia, High-Risk and Very High-Risk MDS Trial (SGR-2921)

Not yet recruiting
  • Acute Myeloid Leukemia
  • High-Risk and Very High-Risk Myelodysplastic Syndromes
  • (no location specified)
Jul 25, 2023

Intensive Conditioning With Thiotepa Combined With Bu/Flu/Ara-C

Not yet recruiting
  • Acute Myeloid Leukemia
  • +4 more
    • (no location specified)
    Nov 1, 2023

    Outcomes in Chronic Myeloid Leukaemia

    Completed
    • Chronic Myeloid Leukaemia
      • York, United Kingdom
        Haematological Malignancy Research Network
      Jun 7, 2023

      Oral Venetoclax Tablets + Subcutaneously Injected Azacitidine in

      Not yet recruiting
      • Acute Myeloid Leukemia
        • (no location specified)
        Sep 22, 2023

        Acute Myeloid Leukemia, Adult Trial in Hangzhou (cladribine + homoharringtonine + cytarabine)

        Recruiting
        • Acute Myeloid Leukemia, Adult
        • cladribine + homoharringtonine + cytarabine
        • Hangzhou, Zhejiang, China
          The First Affiliated Hospital, Zhejiang University School of Med
        Jun 13, 2023

        Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Duarte (Decitabine,

        Active, not recruiting
        • Acute Myeloid Leukemia
        • +5 more
        • Duarte, California
          City of Hope Medical Center
        Jan 4, 2023

        Refractory Acute Myeloid Leukemia, Relapsed Acute Myeloid Leukemia, Acute Myeloid Leukemia Trial in United States

        Recruiting
        • Refractory Acute Myeloid Leukemia
        • +4 more
        • CD371-YSNVZ-IL18 CAR T cells
        • Basking Ridge, New Jersey
        • +6 more
        Aug 29, 2023

        Refractory/Relapse Acute Myeloid Leukemia Trial in Kunming (Venetoclax)

        Recruiting
        • Refractory/Relapse Acute Myeloid Leukemia
        • Kunming, Yunnan, China
          Department of Hematology,920th Hospital of Joint Logistic Suppor
        Mar 28, 2023

        Chronic Myelogenous Leukemia - Chronic Phase Trial in Avignon (APN and medical management, Medical management, Quality of life

        Not yet recruiting
        • Chronic Myelogenous Leukemia - Chronic Phase
        • APN and medical management
        • +3 more
        • Avignon, Provence-Alpes-Côte d'Azur, France
          Centre Hospitalier d'Avignon, Hôpital Henri Duffaut
        Oct 13, 2023

        Venetoclax Plasma Concentration and Remission in Acute Myeloid

        Not yet recruiting
        • Adult Acute Myeloid Leukemia
        • Blood sampling for venetoclax drug dosage (venous puncture)
        • (no location specified)
        Sep 13, 2023

        Acute Myeloid Leukemia Trial in Fuzhou (CLL1/+CD33 CAR-T)

        Not yet recruiting
        • Acute Myeloid Leukemia
        • CLL1/+CD33 CAR-T
        • Fuzhou, Fujian, China
          Fujian Provincial Children's Hospital
        Jul 10, 2023

        Acute Myeloid Leukemia, Acute Myeloid Leukemia Recurrent, Leukemia Trial in Boston (Cytokine-Induced Memory-like Natural Killer

        Not yet recruiting
        • Acute Myeloid Leukemia
        • +3 more
        • Cytokine-Induced Memory-like Natural Killer Cells
        • +2 more
        • Boston, Massachusetts
        • +1 more
        Nov 22, 2023

        Acute Myeloid Leukemia Trial in Suzhou (Venetoclax, Homoharringtonine, Cytarabine)

        Recruiting
        • Acute Myeloid Leukemia
        • Suzhou, Jiangsu, China
          Qiu Huiying
        Mar 28, 2023

        AML Trial in Guanzhou (CLAG)

        Not yet recruiting
        • AML
        • CLAG
        • Guanzhou, Guangdong, China
        • +1 more
        May 16, 2023

        Relapsed/Refractory Acute Myeloid Leukemia Trial in Hangzhou (B7-H3 target, CAR gene modified gdT cell injection)

        Recruiting
        • Relapsed/Refractory Acute Myeloid Leukemia
        • B7-H3 target, CAR gene modified gdT cell injection
        • Hangzhou, Zhejiang, China
          The First Affiliated Hospital， Zhejiang University School of Med
        Feb 15, 2023

        Leukemia, Myeloid, Acute Trial in Guangzhou, Hangzhou (BG1805)

        Not yet recruiting
        • Leukemia, Myeloid, Acute
        • BG1805
        • Guangzhou, Guangdong, China
        • +2 more
        Nov 1, 2023

        Acute Myeloid Leukemia Trial in Kunming (CLL1 and CD38 dual-target CAR-T injection)

        Recruiting
        • Acute Myeloid Leukemia
        • CLL1 and CD38 dual-target CAR-T injection
        • Kunming, Yunnan, China
          920th Hospital of Joint LogisticsSupport Force of People's Liber
        Oct 26, 2023

        GilteRInf 2022 Study (Gilteritinib Related Infections)

        Active, not recruiting
        • Acute Myeloid Leukemia
        • Roma, RM, Italy
          Maria Ilaria Del Principe
        Mar 17, 2023

        Real-World Usage of Asciminib Among Chronic Myeloid Leukemia in

        Completed
        • Chronic Myeloid Leukemia
          • East Hanover, New Jersey
            Novartis
          Nov 20, 2023

          Acute Myeloid Leukemia, MDS, Myeloid Malignancies Trial in Boston (Decitabine, Filgrastim)

          Not yet recruiting
          • Acute Myeloid Leukemia
          • +6 more
          • Boston, Massachusetts
          • +1 more
          Mar 31, 2023

          Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia, Acute Myeloid Leukemia, in Relapse Trial in Miami (Bomedemstat,

          Recruiting
          • Acute Myeloid Leukemia
          • +2 more
          • Miami, Florida
            University of Miami
          Dec 22, 2022

          Acute Myeloid Leukemia Trial in Memphis (Venetoclax, Azacitidine, Cytarabine)

          Not yet recruiting
          • Acute Myeloid Leukemia
          • Memphis, Tennessee
            St. Jude Children's Research Hospital
          Jul 21, 2023

          Allogeneic Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Suzhou

          Recruiting
          • Allogeneic Hematopoietic Stem Cell Transplantation
          • +2 more
          • VEN+AZA+Modified BUCY
          • Suzhou, Jiangsu, China
            The First Affiliated Hospital of Soochow University
          Apr 10, 2023

          Relapsed or Refractory Acute Myeloid Leukemia Trial in Taiyuan (Selinexor, Homoharringtonine, Daunorubicin)

          Recruiting
          • Relapsed or Refractory Acute Myeloid Leukemia
          • Taiyuan, Shanxi, China
            Tao Wang
          Feb 9, 2023

          Acute Myeloid Leukemia Trial in Beijing (Azacytidine;Cytarabine;Aclacinomycin;Chidamide;Venetoclax;Granulocyte

          Recruiting
          • Acute Myeloid Leukemia
          • Azacytidine;Cytarabine;Aclacinomycin;Chidamide;Venetoclax;Granulocyte colony-stimulating factor
          • "3+7"
          • Beijing, Beijing, China
            Chinese PLA General Hospital
          Sep 29, 2023